Protocol for Missed Penicillin G Injection in a 3-Injection Series
If a patient misses their second Penicillin G injection by a week in a 3-injection series, they should resume the sequence of injections without restarting the entire course, as pharmacologic considerations suggest that an interval of 10-14 days between doses is acceptable for late syphilis or latent syphilis of unknown duration. 1
Management Algorithm for Missed Penicillin G Injection
Assessment of Patient Factors:
Determine if the patient is pregnant
- If pregnant: The entire course of therapy must be repeated 1
- If not pregnant: Continue with protocol below
Determine type of syphilis being treated
- Early latent syphilis: Single dose regimen (not applicable to this scenario)
- Late latent or unknown duration syphilis: Three-dose regimen (applicable to this scenario)
Protocol for Non-Pregnant Patients:
- Administer the missed second dose immediately
- Schedule the third dose to be given 1 week after the second dose
- Document the extended interval between first and second doses
- Ensure close follow-up with appropriate serologic testing
Rationale and Evidence
The CDC guidelines specifically address this scenario, stating: "If a patient misses a dose of penicillin in the course of weekly therapy for late syphilis, the appropriate course of action is unclear. Pharmacologic considerations suggest that an interval of 10-14 days between doses of benzathine penicillin for late syphilis or latent syphilis of unknown duration might be acceptable before restarting the sequence of injections." 1
This recommendation is based on the pharmacokinetics of benzathine penicillin G, which maintains treponemicidal serum concentrations for 2-3 weeks after injection. The goal of therapy is to maintain adequate serum penicillin levels to treat the infection effectively.
Special Considerations
For Pregnant Patients:
- Missed doses are not acceptable for pregnant patients receiving therapy for late latent syphilis
- Pregnant women who miss any dose must repeat the full course of therapy 1
- This more conservative approach is due to the risk of congenital syphilis
Follow-Up Recommendations:
- Quantitative nontreponemal serologic tests should be repeated at 6,12, and 24 months 1
- Monitor for signs of treatment failure:
- Fourfold increase in titer
- Failure of initially high titer (>1:32) to decline at least fourfold within 12-24 months
- Development of signs or symptoms attributable to syphilis
Common Pitfalls to Avoid
- Unnecessarily restarting the entire course for non-pregnant patients
- Failing to recognize that pregnant patients require a complete restart of therapy
- Inadequate follow-up serologic testing
- Not documenting the extended interval between injections
- Switching between different nontreponemal tests during follow-up, which can complicate interpretation
By following this protocol, clinicians can ensure appropriate management of patients who miss a dose in their penicillin G treatment series while minimizing the risk of treatment failure and disease progression.